Doze

Columbia Care Introduces New Line of Formulated Cannabis Tablets, PRESS 2.0

Retrieved on: 
Thursday, February 16, 2023
Retail, Alternative Medicine, Specialty, Health, CBG, Magnesium, SVP, Wind, NLRB v. Kentucky River Community Care, Inc., Patient, Cannabis, Doze, THC, CBD, FSE, CSE, NEO, Tablet

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced it has launched several new products under its PRESS brand.

Key Points: 
  • Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced it has launched several new products under its PRESS brand.
  • “A growing number of patients and customers are looking for a discreet and reliable way to consume cannabis – which is exactly what our PRESS brand offers,” said BJ Carretta, SVP of Brands, Columbia Care.
  • PRESS 2.0 is a testament to Columbia Care’s ongoing innovation and drive to serve medical and adult use consumers across our diverse portfolio of states.
  • We look forward to bringing PRESS 2.0 to additional markets.”
    PRESS 2.0 was created as a portable, convenient, and discreet option.